Users online: 2228    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 6
First page : ( 2811) Last page : ( 2814)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00500.4

Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets

Dr Reddy Y. Krishna*, Ahmed Syed Suhaib

Department of Pharmaceutics, Nalanda College of Pharmacy, Jawaharlal Nehru Technological University, Hyderabad, Telangana

*Corresponding Author E-mail: rajinisuralabs1@gmail.com

Online published on 4 July, 2020.


The aim of this research is to formulate and evaluate Doxofylline Oral disintegrating Tablets. Doxofylline Indicated for the treatment of chronic obstructive pulmonary disease (COPD), bronchial asthma and pulmonary disease with spastic bronchial component. Hence in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. With superior dissolution properties with different concentrations. The tablets were prepared by direct compression method. The tablets were evaluated for the pre compression parameters such as bulk density, compressibility, angle of repose etc and post compression parameters like Hardness, weigh variation, friability, disintegration time, In vitro dissolution studies. The formulation F6 consisting of Crospovidone was found be best among all the formulations it has exhibited faster disintegrating time (15 sec) when compared to other formulations and it showed 99.57% drug release in 30min.



Doxofylline Oral disintegrating Tablets, Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
598,507,744 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.